Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels

Verfasser / Beitragende:
[N. Widmer, H. Rumpold, G. Untergasser, A. Fayet, T. Buclin, L.A. Decosterd]
Ort, Verlag, Jahr:
2007
Enthalten in:
Leukemia, 21/7(2007), 1561-2; author reply 1562-4
Format:
Artikel (online)
ID: 439425646